Table 1.
Baseline characteristics
| Characteristics | Group 1 | Group 2 | Group 3 | P-value |
|---|---|---|---|---|
| Sample size, n | 12 | 8 | 7 | |
| Age, years | 52.0±12.2 | 57.8±14.4 | 62.4±8.1 | NS |
| Male gender, n | 5 | 5 | 4 | NS |
| BMI, kg/m2 | 28.8±8.2 | 30.3±7.2 | 27.1±4.5 | NS |
| Beclomethesone, mcg/day | 1,667±492 | 1,875±640 | 1,571±535 | NS |
| Salbutamol puffs/day | 7.3±8.2 | 7.9±7.1 | 8.3±8.4 | NS |
| ACQ-5 | 3.4±1.0 | 3.3±1.4 | 2.8±0.3 | NS |
| FEV1% predicted | 57.1±9.3 | 52.4±14.9 | 54.1±25.8 | NS |
| Forced expiratory ratio | 56.5±7.1 | 54.8±15.6 | 55.0±20.4 | NS |
Notes: All data are presented as mean ± SD unless otherwise specified. Group 1: standard bronchoscope used; Group 2: mixed bronchoscopes used; Group 3: thin bronchoscope used.
Abbreviations: BMI, body mass index; ACQ-5, Asthma Control Questionnaire-5 item; NS, not significant.